Artículo de revista
Statement about the medical and surgical treatment of overweight and obesity Tratamiento farmacológico o quirúrgico del paciente con sobrepeso u obesidad
Fecha
2009Registro en:
Revista Medica de Chile, Volumen 137, Issue 7, 2018, Pages 972-981
00349887
07176163
Autor
Carrasco, Fernando
Manrique, Mónica
Maza Cave, María Pía de la
Moreno, Manuel
Albala Brevis, Cecilia
García, Jaime
Díaz, Jaime
Liberman, Claudio
Institución
Resumen
This is an updated review of the available treatments for obesity, that can be used when lifestyles modifications fail. Using the available information and the experience of the members of this advisory group, a recommendation is given about the most useful treatments, according to the severity of obesity and its complications. With regards to pharmacological treatments, only sibutramine and orlistat are approved on a worldwide basis for the treatment of obesity. These medications achieve a 10% higher weight reduction than lifestyles modification. A third medication, rimonobant, is also more effective than lifestyles modifications, but it was withdrawn due to psychological safety issues. The indications for surgical treatment and a brief description of the available techniques, success rates and complications are outlined. Finally, the need to have follow up protocols for patients and the formation of multidisciplinary treatment teams is underscore.